<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Harborlunge4</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Harborlunge4"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Harborlunge4"/>
		<updated>2026-05-16T14:21:14Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=E_efficacy_of_diacerein_to_slow_the_progression_of_the_disease&amp;diff=279847</id>
		<title>E efficacy of diacerein to slow the progression of the disease</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=E_efficacy_of_diacerein_to_slow_the_progression_of_the_disease&amp;diff=279847"/>
				<updated>2018-01-24T08:38:04Z</updated>
		
		<summary type="html">&lt;p&gt;Harborlunge4: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;E [http://www.medchemexpress.com/Brefeldin-A.html Cyanein side effects] efficacy of diacerein to slow the progression of the disease in an early model of OA, as shown in previous studies in vitro [45], in different animal models [12, 42, 45, 46] and in clinical trials [7, 16, 47]; although the comparison of different studies is difficult because of their high degree of heterogeneity (different models conducted in different animal species and humans, different time schedule and others). Regarding the subchondral bone, diacerein has shown in healthy bone, but not in the osteoarthritic one, the ability to increase bone volume and mineral density, indicating a surprising effect of this drug on the bone structure, whose results have not been published up to now. The study also demonstrates the validity of the animal model, and that micro-CT could be a valid technique to detect morphological changes in articular cartilage with comparable results to histomorphometry. Further studies on long-term OA animal models and well-conducted clinical trials may be required to confirm or exclude the efficacy of diacerein in the treatment of knee OA.Abbreviations OA: Osteoarthritis; SYSADOAs: symptomatic slow-acting drugs for osteoarthritis; NSAIDS: non-steroidal anti-inflammatory drugs; ARRIVE: Animal Research: Reporting in vivo experiments; ACLT: anterior cruciate ligament transection; SO: safranin-O staining; H-E: Hematoxylin-eosin. Competing interests The authors declare that they have no competing interests. Authors' contributions DG, JRC, FM and AGC participated in the conception and design of the study. The animal model and the histological analyses were performed by MP, ML, FM and AGC; micro-CT assessments were conducted by DG and JRC. All authors have [https://dx.doi.org/10.1089/jir.2011.0103 title= jir.2011.0103] collaborated on data analysis, interpretation of results, drafting and revision of article for final approval. Acknowledgements The authors gratefully acknowledge the assistance of Natalia Mi , Mariano L ez and Oscar Varela of the Department of Veterinary Clinical Sciences, University of Santiago de Compostela, for their contribution in surgery procedures and drug administration, of the staff at the Animal Research Facility, University [https://dx.doi.org/10.3389/fnhum.2013.00596 title= fnhum.2013.00596] of Santiago de Compostela, for taking care of the animals and Bioiberica (Barcelona, Spain), which provided drugs for the study. The authors are grateful to the Directorate-General of Research, Development and Innovation, Ministry of Economy and Industry, Xunta de Galicia for funding this work through research project 09CSA008E, co-financed by the European Regional and Social Funds (FEDER and FSE) and by a grant from the Fundaci  Salud 2000. The funders have no role in the study design, data analysis and interpretation, writing of the manuscript or decision to submit it for publication. Author details 1 Veterinary Clinical Sciences, University of Santiago de [http://www.medchemexpress.com/AZD3759.html AZD3759 chemical information] Compostela (USC), Campus Universitario, s/n, 27002, Lugo, Spain. 2Trabeculae S.L., Parque Tecnol ico de Galicia, 32900 San Cibrao das Vi s, Ourense, Spain. 3 Orthopedic Surgery Service, USC University Hospital Complex, Traves  de Choupana, s/n,.E efficacy of diacerein to slow the progression of the disease in an early model of OA, as shown in previous studies in vitro [45], in different animal models [12, 42, 45, 46] and in clinical trials [7, 16, 47]; although the comparison of different studies is difficult because of their high degree of heterogeneity (different models conducted in different animal species and humans, different time schedule and others). ToPermuy et al.&lt;/div&gt;</summary>
		<author><name>Harborlunge4</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Rowne_WJ,_Cuthill_IC,_Emerson_M,_Altman_DG._Improving_Bioscience_Research&amp;diff=279390</id>
		<title>Rowne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Rowne_WJ,_Cuthill_IC,_Emerson_M,_Altman_DG._Improving_Bioscience_Research&amp;diff=279390"/>
				<updated>2018-01-23T06:36:06Z</updated>
		
		<summary type="html">&lt;p&gt;Harborlunge4: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Laverty S, Girard CA, Williams JM, [http://femaclaims.org/members/goalmind24/activity/1086777/ Health-related care may do additional harm than very good [mean value (respondents] Hunziker EB, Pritzker KP. 2010;18:S53?5.Permuy et al. BMC Veterinary Research (2015) 11:Page 11 of24. Pastoureau PC, Hunziker EB, Pelletier JP. Cartilage, bone and synovial [https://dx.doi.org/10.1371/journal.pone.0158910 title= journal.pone.0158910] histomorphometry in animal models of osteoarthritis. Osteoarthritis Cartilage. 2010;18:S106?12. 25. Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Socof Am A. 1984;1:612?. 26. Hahn M, Vogel M, Pompesius-Kempa M, Delling G. Trabecular bone pattern factor - a new parameter for simple quantification of bone microarchitecture. Bone. 1992;13:327?0. 27. Hildebrand T, Laib A, M ler R, Dequeker J, R gsegger P. Direct threedimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999;14:1167?4. 28. Hildebrand T, R gsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng. 1997;1:15?3. 29. Odgaard A, Jensen EB, Gundersen HJ. Estimation of structural anisotropy based on volume orientation. A new concept. J Microsc. 1990;157:149?2. 30. Bendele AM. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact. 2001;1:363?6. 31. Pritzker KP. Animal models for osteoarthritis: processes, problems and prospects. Ann Rheum Dis. 1994;53:406?0. 32. Paatsama S. Ligament injuries of the canine stifle joint: A clinical and experimental study, Master's thesis. Helsinki: Veterinary College; 1952. 33. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005;13:632?1. 34. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayor M, et al. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum. 1973;16:397?05. 35. Calvo E, Palacios I, Delgado E, Ruiz-Cabello J, Hern dez P, S chez-Pernaute O, et al. High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage. 2001;9:463?2. 36. Calvo E, Palacios I, Delgado E, S chez-Pernaute O, Largo R, Egido J, et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis.Rowne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. Osteoarthritis Cartilage. 2012;20:256?0. 19. Permuy M, Guede D, L ez-Pe  M, Mu z F, Gonz ez-Cantalapiedra A, Caeiro JR. Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. BMC Vet Res. 2014;10:97. 20. Donath K. The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (S e-Schliff (sawing and grinding) technique). Pathol Res Pract. 1985;179:631?. 21. Laczk?J, L ai G. A simple differential staining method for semi-thin sections of ossifying cartilage and bone tissues embedded in epoxy resin. BMC Veterinary Research (2015) 11:Page 11 of24. Pastoureau PC, Hunziker EB, Pelletier JP. Cartilage, bone and synovial [https://dx.doi.org/10.1371/journal.pone.0158910 title= journal.pone.0158910] histomorphometry in animal models of osteoarthritis. Osteoarthritis Cartilage. 2010;18:S106?12. 25. Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Socof Am A. 1984;1:612?.&lt;/div&gt;</summary>
		<author><name>Harborlunge4</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Non-calcified_cartilage._Previous_studies_revealed_the_beneficial_effect_of_this_drug&amp;diff=278893</id>
		<title>Non-calcified cartilage. Previous studies revealed the beneficial effect of this drug</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Non-calcified_cartilage._Previous_studies_revealed_the_beneficial_effect_of_this_drug&amp;diff=278893"/>
				<updated>2018-01-22T02:12:09Z</updated>
		
		<summary type="html">&lt;p&gt;Harborlunge4: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The histologic evaluation of the synovial membrane in the OA group revealed moderate to severe inflammatory [http://www.share-dollar.com/comment/html/?33425.html Cer.Conclusions The results of our study indicate the potential role] changes with [http://www.xxxyyl.com/comment/html/?108924.html Ocusing extra on peripheral leukocyte sensitivity for the duration of bolus infusion administration (102?04). A possible explanation could be the substantial variability due to the use of a qualitative subjective scoring system for their evaluation; another explanation (comparing these results with the calcified samples) could be that due to decalcification the integrity of the samples (chiefly bone and calcified cartilage) per.1944 may have been altered [24]. However, in decalcified samples, the results for the OA + DC group were closer to normality than those obtained for the OA group. In the samples evaluated by a histomorphometric quantitative methodology, results showed improvement in the diacerein-treated group compared to the one treated with placebo, although differences were not significant. In cartilage parameters there were statistical differences in Cg.Th and nCg.Th between the OA group and the CTRL + DC group and for the latter also with the CTRL group.Non-calcified cartilage. Previous studies revealed the beneficial effect of this drug not only for cartilage protection, but also for synovitis and reduction in bone erosion in a mice model of inflammatory arthritis [41]. The mechanisms of the antiinflammatory effect of diacerein have not yet been completely clarified but Tamura et al. (2002) [42] demonstrated, using inflammatory animal models, a different spectrum of anti-inflammatory activity of diacerein than those of NSAIDs, which may be due to the inhibition of IL-1 and the production of reactive oxygen species [42, 43]. The histologic evaluation of the synovial membrane in the OA group revealed moderate to severe inflammatory changes with thickening of the lining cell layer, hyperplasia and infiltration with inflammatory cells. In the diacerein-treated group (OA + DC) these changes are milder than in the OA group, although, as in a canine cruciate-deficiency model [12] the results are not statistically significant, as the animals of this OA + DC group obtained values halfway between healthy and osteoarthritic ones. The same results were observed inthe cartilage, where a reduction of the thickness is observed in treated animals with respect to the OA group. In the paraffin-embedded samples there were no differences between groups (although the cartilage pathology is almost significant). A possible explanation could be the substantial variability due to the use of a qualitative subjective scoring system for their evaluation; another explanation (comparing these results with the calcified samples) could be that due to decalcification the integrity of the samples (chiefly bone and calcified cartilage) per.1944 may have been altered [24]. However, in decalcified samples, the results for the OA + DC group were closer to normality than those obtained for the OA group. In the samples evaluated by a histomorphometric quantitative methodology, results showed improvement in the diacerein-treated group compared to the one treated with placebo, although differences were not significant. In cartilage parameters there were statistical differences in Cg.Th and nCg.Th between the OA group and the CTRL + DC group and for the latter also with the CTRL group. There were no differences between OA and OA + DC, but nor between OA + DC and CTRL + DC and the tendency of values was to approximate joint values to normal. Regarding FI -an important parameter because it makes a clear distinction between ill and healthy animals [44]- there were no statistical differences between groups, but there fnins.2013.00251 is a tendency of approximating values of OA + DC to those of controls.]&lt;/div&gt;</summary>
		<author><name>Harborlunge4</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Non-calcified_cartilage._Previous_studies_revealed_the_beneficial_effect_of_this_drug&amp;diff=278892</id>
		<title>Non-calcified cartilage. Previous studies revealed the beneficial effect of this drug</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Non-calcified_cartilage._Previous_studies_revealed_the_beneficial_effect_of_this_drug&amp;diff=278892"/>
				<updated>2018-01-22T02:11:36Z</updated>
		
		<summary type="html">&lt;p&gt;Harborlunge4: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;(2002) [42] demonstrated, using inflammatory animal models, a different spectrum of anti-inflammatory activity of diacerein than those of NSAIDs, which may be due to the inhibition of IL-1 and the production of reactive oxygen species [42, 43]. The histologic evaluation of the synovial membrane in the OA group revealed moderate to severe inflammatory changes with [http://www.xxxyyl.com/comment/html/?108924.html Ocusing extra on peripheral leukocyte sensitivity for the duration of bolus infusion administration (102?04). Far more] thickening of the lining cell layer, hyperplasia and infiltration with inflammatory cells. In the diacerein-treated group (OA + DC) these changes are milder than in the OA group, although, as in a canine cruciate-deficiency model [12] the results are not statistically significant, as the animals of this OA + DC group obtained values halfway between healthy and osteoarthritic ones. The same results were observed inthe cartilage, where a reduction of the thickness is observed in treated animals with respect to the OA group. In the paraffin-embedded samples there were no differences between groups (although the cartilage pathology is almost significant). A possible explanation could be the substantial variability due to the use of a qualitative subjective scoring system for their evaluation; another explanation (comparing these results with the calcified samples) could be that due to decalcification the integrity of the samples (chiefly bone and calcified cartilage) [https://dx.doi.org/10.1002/per.1944 title= per.1944] may have been altered [24]. However, in decalcified samples, the results for the OA + DC group were closer to normality than those obtained for the OA group. In the samples evaluated by a histomorphometric quantitative methodology, results showed improvement in the diacerein-treated group compared to the one treated with placebo, although differences were not significant. Regarding FI -an important parameter because it makes a clear distinction between ill and healthy animals [44]- there were no statistical differences between groups, but there [https://dx.doi.org/10.3389/fnins.2013.00251 title= fnins.2013.00251] is a tendency of approximating values of OA + DC to those of controls. The results obtained from the undecalcified samples were better than those from the decalcified ones because of a better conservation of the tissue structure and because the computer evaluation has a greater degree of objectivity, accuracy and reproducibility, as well as the micro-CT [24], with comparable results between both. In our study, the subchondral bone showed no statistical differences, so further studies may be needed in this regard. Micro-CT data have shown an anabolic effect of diacerein on subchondral trabecular microstructure in both healthy and osteoarthritic samples (though less pronounced in the latter). At the same time, the treatment has been able to stop the swelling of cartilage in OA samples, recovering nCg.Th and nCg.V values very close to the CTRL group.Non-calcified cartilage. Previous studies revealed the beneficial effect of this drug not only for cartilage protection, but also for synovitis and reduction in bone erosion in a mice model of inflammatory arthritis [41]. The mechanisms of the antiinflammatory effect of diacerein have not yet been completely clarified but Tamura et al. (2002) [42] demonstrated, using inflammatory animal models, a different spectrum of anti-inflammatory activity of diacerein than those of NSAIDs, which may be due to the inhibition of IL-1 and the production of reactive oxygen species [42, 43]. The histologic evaluation of the synovial membrane in the OA group revealed moderate to severe inflammatory changes with thickening of the lining cell layer, hyperplasia and infiltration with inflammatory cells.&lt;/div&gt;</summary>
		<author><name>Harborlunge4</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Rowne_WJ,_Cuthill_IC,_Emerson_M,_Altman_DG._Improving_Bioscience_Research&amp;diff=278876</id>
		<title>Rowne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Rowne_WJ,_Cuthill_IC,_Emerson_M,_Altman_DG._Improving_Bioscience_Research&amp;diff=278876"/>
				<updated>2018-01-22T01:39:14Z</updated>
		
		<summary type="html">&lt;p&gt;Harborlunge4: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Rowne WJ, Cuthill IC, Emerson M, [http://www.medchemexpress.com/Avasimibe.html buy CI-1011] Altman DG. 2012;20:256?0. 19. Permuy M, Guede D, L ez-Pe  M, Mu z F, Gonz ez-Cantalapiedra A, Caeiro JR. Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. BMC Vet Res. 2014;10:97. 20. Donath K. The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (S e-Schliff (sawing and grinding) technique). Pathol Res Pract. 1985;179:631?. 21. Laczk?J, L ai G. A simple differential staining method for semi-thin sections of ossifying cartilage and bone tissues embedded in epoxy resin. Mikroskopie. 1975;31:1?. 22. Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis Cartilage. 2010;18:S66?9. 23. Laverty S, Girard CA, Williams JM, Hunziker EB, Pritzker KP. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the [https://dx.doi.org/10.4278/ajhp.120120-QUAN-57 title= ajhp.120120-QUAN-57] rabbit. Osteoarthritis Cartilage. 2010;18:S53?5.Permuy et al. BMC Veterinary Research (2015) 11:Page 11 of24. Pastoureau PC, Hunziker EB, Pelletier JP. Cartilage, bone and synovial [https://dx.doi.org/10.1371/journal.pone.0158910 title= journal.pone.0158910] histomorphometry in animal models of osteoarthritis. Osteoarthritis Cartilage. 2010;18:S106?12. 25. Feldkamp LA, Davis LC, Kress JW. [http://www.medchemexpress.com/Avasimibe.html Avasimibe web] Practical cone-beam algorithm. J Opt Socof Am A. 1984;1:612?. 26. Hahn M, Vogel M, Pompesius-Kempa M, Delling G. Trabecular bone pattern factor - a new parameter for simple quantification of bone microarchitecture. Bone. Estimation of structural anisotropy based on volume orientation. A new concept. J Microsc. 1990;157:149?2. 30. Bendele AM. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact. 2001;1:363?6. 31. Pritzker KP. Animal models for osteoarthritis: processes, problems and prospects. Ann Rheum Dis. 1994;53:406?0. 32. Paatsama S. Ligament injuries of the canine stifle joint: A clinical and experimental study, Master's thesis. Helsinki: Veterinary College; 1952. 33. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005;13:632?1. 34. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayor M, et al. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum. 1973;16:397?05. 35. Calvo E, Palacios I, Delgado E, Ruiz-Cabello J, Hern dez P, S chez-Pernaute O, et al. High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage. 2001;9:463?2. 36. Calvo E, Palacios I, Delgado E, S chez-Pernaute O, Largo R, Egido J, et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage.Rowne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. Osteoarthritis Cartilage. 2012;20:256?0. 19. Permuy M, Guede D, L ez-Pe  M, Mu z F, Gonz ez-Cantalapiedra A, Caeiro JR. Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. BMC Vet Res. 2014;10:97. 20. Donath K. The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (S e-Schliff (sawing and grinding) technique).&lt;/div&gt;</summary>
		<author><name>Harborlunge4</name></author>	</entry>

	</feed>